BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18636145)

  • 1. VEGF blockade decelerates the growth of a murine experimental osteosarcoma.
    Yin D; Jia T; Gong W; Yu H; Wooley PH; Mott MP; Yang SY
    Int J Oncol; 2008 Aug; 33(2):253-9. PubMed ID: 18636145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retros Flt-1 decelerates the growth of a murine experimental osteosarcoma].
    Xin XT; Yin DZ; Lan H; Chen C; Liu B; Yang SY
    Zhonghua Wai Ke Za Zhi; 2011 Aug; 49(8):746-51. PubMed ID: 22168943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
    Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K
    Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP
    J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
    Mahasreshti PJ; Kataram M; Wang MH; Stockard CR; Grizzle WE; Carey D; Siegal GP; Haisma HJ; Alvarez RD; Curiel DT
    Clin Cancer Res; 2003 Jul; 9(7):2701-10. PubMed ID: 12855650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of soluble vascular endothelial growth factor (VEGF) receptor gene (sflt-1) and antisense VEGF nucleotide on neovascularization].
    Mi J; Wang JH; Chen SS
    Ai Zheng; 2002 May; 21(5):464-8. PubMed ID: 12452033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
    Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice.
    Kim WJ; Yockman JW; Jeong JH; Christensen LV; Lee M; Kim YH; Kim SW
    J Control Release; 2006 Sep; 114(3):381-8. PubMed ID: 16884805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys.
    Lai CM; Shen WY; Brankov M; Lai YK; Barnett NL; Lee SY; Yeo IY; Mathur R; Ho JE; Pineda P; Barathi A; Ang CL; Constable IJ; Rakoczy EP
    Mol Ther; 2005 Oct; 12(4):659-68. PubMed ID: 16023893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Zhang Z; Zou W; Wang J; Gu J; Dang Y; Li B; Zhao L; Qian C; Qian Q; Liu X
    Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
    Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC
    J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor.
    Mahendra G; Kumar S; Isayeva T; Mahasreshti PJ; Curiel DT; Stockardt CR; Grizzle WE; Alapati V; Singh R; Siegal GP; Meleth S; Ponnazhagan S
    Cancer Gene Ther; 2005 Jan; 12(1):26-34. PubMed ID: 15359287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment modifications induced by soluble VEGF receptor expression in a rat liver metastasis model.
    Bertin S; Mohsen-Kanson T; Baqué P; Gavelli A; Momier D; Anjuere F; Carle GF; Pierrefite-Carle V
    Cancer Lett; 2010 Dec; 298(2):264-72. PubMed ID: 20702033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis.
    Afuwape AO; Feldmann M; Paleolog EM
    Gene Ther; 2003 Nov; 10(23):1950-60. PubMed ID: 14528319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor.
    Huckle WR; Roche RI
    J Cell Biochem; 2004 Sep; 93(1):120-32. PubMed ID: 15352169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.
    Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY
    Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts.
    Gao ZN; Wei YQ; Yang PS; Xu X; Zhao HQ; Huan X; Kang B
    Oral Oncol; 2007 May; 43(5):477-83. PubMed ID: 16997614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of human colon cell line Lovo transfected with soluble vascular endothelial growth factor receptor 1 gene].
    Zheng CX; Wu RY; Chen LH; Tan M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):416-9. PubMed ID: 19598033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
    Kornek M; Raskopf E; Tolba R; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Liver Int; 2008 Apr; 28(4):509-18. PubMed ID: 18339078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.
    Oyama M; Tatlock A; Fukuta S; Kavalkovich K; Nishimura K; Johnstone B; Robbins PD; Evans CH; Niyibizi C
    Gene Ther; 1999 Mar; 6(3):321-9. PubMed ID: 10435082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.